Julius Clinical
Niki De Vink - Bär is a seasoned professional in the field of clinical regulatory affairs with extensive experience at Julius Clinical since July 2014, where Niki holds the position of Senior Manager Regulatory. In this role, Niki provides strategic direction and leadership within the Regulatory department, overseeing the (inter)national clinical regulatory submission and approval processes, and advising clients and project teams. Previous positions include Manager Regulatory and Clinical Regulatory Manager, during which Niki established and built the Regulatory department. Prior to Julius Clinical, Niki worked at Sanofi in various capacities, including Ad Interim Regional Clinical Project Leader and Senior Clinical Research Associate, focusing on the operational conduct of clinical trials and supporting monitoring teams in Europe. Niki's educational background includes a Master of Science in Health Promotion from Maastricht University and additional studies at The University of Texas, Health Science Center at Houston.
This person is not in the org chart
Julius Clinical
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases. Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget. Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.